Explore evidence

Gold tier: mechanically validated evidence, with its primary source.

1,197 evidence items · page 42 / 48

52 %The proportion of children under 5 years in the population of patients with confirmed malaria decreased from 52% to 26% after the seasonal malaria chemoprevention intervention was introduced in 2012.

Malipaludismeobserved 2012HAL · Unilimdocument of 111 observations

31.9 %Among 266 COVID-19 donor samples, 85 (31.9%) recognized the RBM protein.

MaliCOVID-19HAL · Unilimdocument of 67 observations

19 health_districtsIn Mali, 19 health districts were selected to receive the malaria vaccine in 2025 due to high and moderate malaria transmission and high infant and child mortality rates.

Malipaludismeobserved 2025HAL · Unilimdocument of 95 observations

33,160 casesIn November 2023, Mali officially recorded 33,160 confirmed COVID-19 cases.

MaliCOVID-19observed November 2023HAL · Unilimdocument of 88 observations

0.87 %Le taux de co-infection mixte par Plasmodium falciparum et Plasmodium ovale était de 0,87 %.

MalipaludismeHAL · Unilimdocument of 31 observations

Sickle cell disease is associated with unacceptable morbidity and mortality rates in the absence of diagnosis and care.

MalidrépanocytoseHAL · Unilimdocument of 103 observations

820.6 per_1000_person_yearsThe highest malaria incidence was 820.6 cases per 1,000 person-years in the health district of Yorosso (Sikasso region in the south) in the year 2019–2020.

Malipaludismeobserved 2019–2020HAL · Unilimdocument of 111 observations

2 %L'accès aux structures de santé pour le test COVID-19 après référence par les agents de santé communautaires était de 2 % (10 sur 449 patients).

MaliCOVID-19observed 2022HAL · Unilimdocument of 36 observations

0.8 %The reported incidence of SARS-CoV-2 in the urban commune of Tombouctou was 0.8% during January 2021.

MaliCOVID-19observed January 2021HAL · Unilimdocument of 88 observations

36.7 %Linkage-to-care for sickle cell disease newborns was effective for only 36.7% (22/60) within the first 6 months.

Malidrépanocytoseobserved first 6 monthsHAL · Unilimdocument of 103 observations

0.25 per_hourThe parasite clearance rate constant was 0.25 per hour for artemether-lumefantrine.

Malipaludismepublished 2018Malaria journaleurope_pmcdocument of 9 observations

40,000 personsThe Sickle Pan-African Research Consortium (SPARCo) registry includes data from over 40,000 persons living with sickle cell disease in seven African countries.

Ghana · Mali · Nigeria · Ouganda · Tanzanie · Zambie · Zimbabwedrépanocytosepublished 2026Database : the journal of biological databases and curationeurope_pmc

71.9 %In the COVID-19 sample group (N = 266), the prevalence of antibody responders against RBD was 71.9% among males.

MaliCOVID-19 · SARS-CoV-2 RBDHAL · Unilimdocument of 67 observations

97.5 %Les tests de diagnostic rapide ont une sensibilité de 95-100 % lorsque la parasitémie atteint 2000 parasites/μl.

MalipaludismeHAL · Unilimdocument of 214 observations

6 %Le Mali contribue à 6 % des cas de paludisme en Afrique de l’Ouest.

MalipaludismeHAL · Unilimdocument of 214 observations

58 %58% of mothers did not know the causes of sickle cell disease.

Malidrépanocytosepublished 2009Мир науки, культуры, образованияOpenAlexdocument of 12 observations

830 isolatesThis study assessed genetic variation with 830 Malian Plasmodium falciparum isolates collected between 2007 and 2017.

Malipaludismeobserved 2007–2017published 2022Frontiers in geneticseurope_pmcdocument of 5 observations

90.4 %Complete genotyping was achieved for 90.4% (75 out of 83) of the qPCR-positive samples.

Malipaludismepublished 2016The American journal of tropical medicine and hygieneeurope_pmcdocument of 2 observations

3 mutationsThree K13-propeller mutations were observed in more than one country in sub-Saharan Africa.

Malipaludismepublished 2015The Journal of infectious diseaseseurope_pmcdocument of 4 observations

136 samplesA total of 136 blood samples were collected in 2014 from children with clinical malaria in Moissala Health District.

Malipaludismeobserved 2014published 2025Malaria journaleurope_pmcdocument of 5 observations

96.77 %La fréquence des monoinfections à Plasmodium falciparum chez les individus symptomatiques était de 96,77 %.

MalipaludismeHAL · Unilimdocument of 214 observations

77 %In children who received RTS,S/AS01E vaccine in Burkina Faso and Mali, 77% showed a 2-fold increase in anti-CSP IgG antibody titres post-2019 as measured by Oxford MSD assay.

Burkina Faso · Malipaludismeobserved post-2019HAL · Unilimdocument of 105 observations

3.2 %Chez les 95 patients du groupe Kollé, 3 présentaient des formes asexuées de Plasmodium malariae, soit 3,2 %.

MalipaludismeHAL · Unilimdocument of 62 observations

62 %Eighty-eight (62%) of 143 non-malaria comparisons shed CMV at day 0.

Malicytomegalovirus (CMV)published 2016Journal of clinical virology : the official publication of the Pan American Society for Cleurope_pmcdocument of 6 observations

29.5 %Prevalence of parasitaemia was 29.5% in the comparison district prior to seasonal malaria chemoprevention (SMC).

Maliparasitemiaobserved July 2014published 2017Malaria journaleurope_pmcdocument of 10 observations

Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.